Showing results (1111-1120 of 1,186) with videos related to

Sort By:
Pageof 119
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 3, 2015
Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP studyAnita R Peoples, Peter W Bushunow, Sheila N Garland, et al.
The CRISPR Journal|September 7, 2022
Efficient Homology-Directed Repair with Circular Single-Stranded DNA DonorsSukanya Iyer, Aamir Mir, Joel Vega-Badillo, et al.
Chronic Stress (Thousand Oaks, Calif.)|April 18, 2022
Prefrontal Glutamate Neurotransmission in PTSD: A Novel Approach to Estimate Synaptic Strength in Vivo in HumansLynnette A Averill, Lihong Jiang, Prerana Purohit, et al.
Molecular and Cellular Biology|July 23, 2008
Multiple and specific mRNA processing targets for the major human hnRNP proteinsJulian P Venables, Chu-Shin Koh, Ulrike Froehlich, et al.
Environmental Research|January 30, 2026
Associations of fine particulate matter pollution components with overall, prostate cancer, and cardiovascular disease mortality in men with prostate cancer: A cohort studyHari S Iyer, Marley Perlstein, Stefanie A Joseph, et al.
Cancer Research|September 23, 2003
CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumorsChin Pan, Pina M Cardarelli, Matthew H Nieder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 30, 2015
Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British ColumbiaPeter Phillips, Eleni Galanis, Laura MacDougall, et al.
American Journal of Epidemiology|May 4, 2023
Influence of Neighborhood Social and Natural Environment on Prostate Tumor Histology in a Cohort of Male Health ProfessionalsHari S Iyer, Jane B Vaselkiv, Konrad H Stopsack, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2003
Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosisJunichiro Matsuda, Osamu Suzuki, Akihiro Oshima, et al.
Molecular Genetics and Metabolism|December 3, 2009
A validated disease severity scoring system for Fabry diseaseEdward H Giannini, Atul B Mehta, Max J Hilz, et al.
Pageof 119